Vor Biopharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vor Biopharma and other ETFs, options, and stocks.

About VOR

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies.

CEO

Bob Ang

CEOBob Ang

Employees

168

Employees168

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2015

Founded2015

Employees

168

Employees168

VOR Key Statistics

Market cap

91.37M

Market cap91.37M

Price-Earnings ratio

-0.79

Price-Earnings ratio-0.79

Dividend yield

—

Dividend yield—

Average volume

648.38K

Average volume648.38K

High today

$1.40

High today$1.40

Low today

$1.31

Low today$1.31

Open price

$1.32

Open price$1.32

Volume

23.09K

Volume23.09K

52 Week high

$2.50

52 Week high$2.50

52 Week low

$0.63

52 Week low$0.63

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

Vor Biopharma

Why Robinhood?

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. Show more

VOR Key Statistics

Analyst ratings

100%

Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies.